BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9553170)

  • 1. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas.
    Kunishio K; Morisaki K; Matsumoto Y; Nagao S; Nishiyama Y
    Neurol Med Chir (Tokyo); 2003 Dec; 43(12):573-80; discussion 581. PubMed ID: 14723263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
    Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
    Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression in pituitary adenoma.
    Kunishio K; Okada M; Matsumoto Y; Nagao S; Nishiyama Y
    J Med Invest; 2006 Aug; 53(3-4):285-91. PubMed ID: 16953066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of brain tumours with (99m)Tc-MIBI SPET.
    Baldari S; Restifo Pecorella G; Cosentino S; Minutoli F
    Q J Nucl Med; 2002 Dec; 46(4):336-45. PubMed ID: 12411875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-MIBI and 201Tl SPET in the detection of recurrent brain tumours after radiation therapy.
    Yamamoto Y; Nishiyama Y; Toyama Y; Kunishio K; Satoh K; Ohkawa M
    Nucl Med Commun; 2002 Dec; 23(12):1183-90. PubMed ID: 12464783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.
    Soler C; Beauchesne P; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
    Eur J Nucl Med; 1998 Dec; 25(12):1649-57. PubMed ID: 9871097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 99Tcm-MIBI with 201Tl chloride SPET in patients with malignant brain tumours.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Satoh K; Kunishio K; Ohkawa M
    Nucl Med Commun; 2001 Jun; 22(6):631-9. PubMed ID: 11403173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of brain tumor by 99mTc-MIBI: comparison study with 201Tl and predictivity of therapeutic effect].
    Nagamachi S; Jinnouchi S; Flores LG; Kodama T; Ohnishi T; Nakahara H; Futami S; Tamura S; Watanabe K; Yokogami K; Kawano H; Wakisaka S
    Kaku Igaku; 1998 Mar; 35(3):121-30. PubMed ID: 9594487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new semiquantitative method for comparing brain tumor uptake of Tc-99m sestamibi and TI-201.
    San Pedro EC; Yilmaz M; Liu HG; Rosenfeld SS; Mountz JM
    Clin Nucl Med; 1999 Nov; 24(11):868-73. PubMed ID: 10551470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2004 May; 10(9):1281-5. PubMed ID: 15112342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
    Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
    Tatsumi M; Tsuruo T; Nishimura T
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
    Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
    Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presurgical (99m)Tc-sestamibi brain SPET/CT versus SPET: a comparison with MRI and histological data in 33 patients with brain tumours.
    Cecchin D; Chondrogiannis S; Della Puppa A; Rotilio A; Zustovich F; Manara R; Gardiman M; Berti F; Zucchetta P; Carollo C; Bui F
    Nucl Med Commun; 2009 Sep; 30(9):660-8. PubMed ID: 19561554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.